Indeed, increased levels of circulating ANGPTL4 induce both lipogenesis and activation of PKCζ and ceramides production, leading to a pro-inflammatory microenvironment and facilitating progression in NAFLD and NASH [89]. Here, ANGPTL4 is linked to metabolic dysfunction-associated steatotic liver disease.